On Friday, Tenaya Therapeutics Inc (NASDAQ: TNYA) was 12.02% up from the session before settling in for the closing price of $0.44. A 52-week range for TNYA has been $0.39 – $4.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 45.89%. With a float of $134.09 million, this company’s outstanding shares have now reached $162.58 million.
Considering the fact that the conglomerate employs 97 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tenaya Therapeutics Inc stocks. The insider ownership of Tenaya Therapeutics Inc is 17.52%, while institutional ownership is 20.39%. The most recent insider transaction that took place on Mar 10 ’25, was worth 1,336. In this transaction SVP, Finance of this company sold 2,482 shares at a rate of $0.54, taking the stock ownership to the 99,690 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Chief Medical Officer sold 7,398 for $0.54, making the entire transaction worth $3,983. This insider now owns 174,793 shares in total.
Tenaya Therapeutics Inc (TNYA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.89% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
You can see what Tenaya Therapeutics Inc (TNYA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Compared to the last year’s volume of 3.3 million, its volume of 2.94 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 28.55%. Additionally, its Average True Range was 0.08.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 2.73%, which indicates a significant decrease from 30.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.95% in the past 14 days, which was lower than the 201.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7631, while its 200-day Moving Average is $1.9825. Nevertheless, the first resistance level for the watch stands at $0.5157 in the near term. At $0.5386, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5842. If the price goes on to break the first support level at $0.4472, it is likely to go to the next support level at $0.4016. Should the price break the second support level, the third support level stands at $0.3787.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are 87,583K outstanding shares of the company, which has a market capitalization of 80.14 million. As of now, sales total 0 K while income totals -111,130 K. Its latest quarter income was 0 K while its last quarter net income were -23,840 K.
